Literature DB >> 29900913

A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: A randomized clinical trial.

Gargi Saran1, Deepak Umapathy1, Neeta Misra1, Shivakumar Ganiga Channaiah1, Priya Singh1, Saurabh Srivastava1, Sahana Shivakumar1.   

Abstract

BACKGROUND: : Oral submucous fibrosis (OSMF) is a most prevalent potentially malignant disorder associated with betel quid chewing frequently observed in the Indian population. The present study conducted is much of a keen interest because there is much new information, both in the press and the medical literature, about the benefits of fresh fruits and vegetables and antioxidants (such as lycopene and curcumin) for both prevention and treatment of diseases. As clinicians, we often prescribe medications with significant adverse effects, and certainly, if armed with evidence to support using such antioxidants as safer therapeutic alternatives for treatment of OSMF. AIMS AND
OBJECTIVE: The aim of the study was to compare and evaluate the efficacy of lycopene and curcumin given orally in clinically diagnosed OSMF patients.
MATERIALS AND METHODS: Sixty patients were divided randomly into two groups Group A and Group B. After fulfilling the eligibility criteria, sixty patients were randomly allotted based on fishbowl method into thirty each. This technique eliminated the selection bias arising in the study. Group A individuals were treated with 4 mg of lycopene and Group B individuals were given 300 mg of curcumin thrice daily for 3 months. Both the groups were assessed in terms of mouth opening and burning sensation. The statistical analysis was done using SPSS Version 16.0 statistical Analysis Software.
RESULTS: In Group A, the initial burning sensation was 65.83 ± 3.98%, and in Group B, it was 62.33 ± 5.22% (visual analog scale). After 3 months, there was complete cessation of burning sensation in both the groups. Burning sensation between the groups was statistically nonsignificant (P > 0.05). In Group A, mean mouth opening at baseline (1st visit) observed was 3.17 ± 0.08 cm which improved to 3.52 ± 0.07 cm after 3 months of the treatment period. In Group B, mean mouth opening at baseline (1st visit) observed was 3.32 ± 0.07 cm which improved to 3.52 ± 0.08 cm after 3 months of the treatment period. On comparing intergroup, the difference was statistically nonsignificant (P > 0.05). However, on comparing intergroup, average percent change in mean mouth opening from 1st visit to subsequent time intervals across the time period was found to be statistically significant (P < 0.05). Group A showed 11.1 ± 1.0% improvement in mean mouth opening and Group B showed 6.2 ± 0.4% improvement in the mean mouth opening from the 1st visit till the posttreatment period. The change in the mean mouth opening from 1st visit till posttreatment in Group A was 0.35 ± 0.14, and in Group B, it was 0.20 ± 0.09.
CONCLUSION: Lycopene showed better results than curcumin in improving mouth opening; both the drugs were equally effective in decreasing burning sensation in OSMF patients.

Entities:  

Keywords:  Antioxidants; curcumin; lycopene; noninvasive; oral submucous fibrosis; treatment

Mesh:

Substances:

Year:  2018        PMID: 29900913     DOI: 10.4103/ijdr.IJDR_551_16

Source DB:  PubMed          Journal:  Indian J Dent Res        ISSN: 0970-9290


  11 in total

1.  [Efficacy of curcumin in the treatment of oral submucous fibrosis: a Meta-analysis].

Authors:  Jin-Cai Guo; Hui Xie; Hao Wu; Tie-Jun Tong
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-04-01

Review 2.  Efficacy of lycopene in management of Oral Submucous Fibrosis- A systematic review and meta-analysis.

Authors:  Neha Gupta; Ashita Kalaskar; Ritesh Kalaskar
Journal:  J Oral Biol Craniofac Res       Date:  2020-09-17

Review 3.  A Comprehensive Analysis of the Role of Oxidative Stress in the Pathogenesis and Chemoprevention of Oral Submucous Fibrosis.

Authors:  Luciano Saso; Ahmad Reza; Emily Ng; Kimtrang Nguyen; Sheng Lin; Pangzhen Zhang; Paolo Junior Fantozzi; Guliz Armagan; Umberto Romeo; Nicola Cirillo
Journal:  Antioxidants (Basel)       Date:  2022-04-28

4.  Medicinal management of oral submucous fibrosis in the past decade- A systematic review.

Authors:  Chandramani B More; Deepa Jatti Patil; Naman R Rao
Journal:  J Oral Biol Craniofac Res       Date:  2020-08-19

Review 5.  From Simple Mouth Cavities to Complex Oral Mucosal Disorders-Curcuminoids as a Promising Therapeutic Approach.

Authors:  Sosmitha Girisa; Aviral Kumar; Varsha Rana; Dey Parama; Uzini Devi Daimary; Saman Warnakulasuriya; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-17

6.  Evaluation of Efficacy of Curcumin along with Lycopene and Piperine in the Management of Oral Submucous Fibrosis.

Authors:  Basudev Mahato; Chandraday Prodhan; Samir Mandal; Avirup Dutta; Parna Kumar; Tushar Deb; Tarun Jha; Keya Chaudhuri
Journal:  Contemp Clin Dent       Date:  2019 Jul-Sep

7.  Effect of Lycopene on Oral Squamous Cell Carcinoma Cell Growth by Inhibiting IGF1 Pathway.

Authors:  Anqi Tao; Xing Wang; Cuiying Li
Journal:  Cancer Manag Res       Date:  2021-01-26       Impact factor: 3.989

Review 8.  Research Achievements of Oral Submucous Fibrosis: Progress and Prospect.

Authors:  Hui Xu; Feng-Yuan Lyu; Jiang-Yuan Song; Yu-Ming Xu; Er-Hui Jiang; Zheng-Jun Shang; Li-Li Chen; Zhi Xu
Journal:  Biomed Res Int       Date:  2021-03-18       Impact factor: 3.411

Review 9.  An overview of effect of lycopene and curcumin in oral leukoplakia and oral submucous fibrosis.

Authors:  Tanveer Ahmad; Imran Khan; M Moshahid Rizvi; Mohd Saalim; Nikhat Manzoor; Asia Sultana
Journal:  Natl J Maxillofac Surg       Date:  2021-12-13

Review 10.  Turmeric in the management of oral submucous fibrosis - A systematic review and meta-analysis.

Authors:  Ekta Ingle
Journal:  Int J Health Sci (Qassim)       Date:  2020 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.